Literature DB >> 21636652

Acyl depsipeptide (ADEP) resistance in Streptomyces.

Myriam Gominet1, Nicolas Seghezzi1, Philippe Mazodier1.   

Abstract

ADEP, a molecule of the acyl depsipeptide family, has an antibiotic activity with a unique mode of action. ADEP binding to the ubiquitous protease ClpP alters the structure of the enzyme. Access of protein to the ClpP proteolytic chamber is therefore facilitated and its cohort regulatory ATPases (ClpA, ClpC, ClpX) are not required. The consequent uncontrolled protein degradation in the cell appears to kill the ADEP-treated bacteria. ADEP is produced by Streptomyces hawaiiensis. Most sequenced genomes of Streptomyces have five clpP genes, organized as two distinct bicistronic operons, clpP1clpP2 and clpP3clpP4, and a single clpP5 gene. We investigated whether the different Clp proteases are all sensitive to ADEP. We report that ClpP1 is a target of ADEP whereas ClpP3 is largely insensitive. In wild-type Streptomyces lividans, clpP3clpP4 expression is constitutively repressed and the reason for the maintenance of this operon in Streptomyces has been elusive. ClpP activity is indispensable for survival of actinomycetes; we therefore tested whether the clpP3clpP4 operon, encoding an ADEP-insensitive Clp protease, contributes to a mechanism of ADEP resistance by target substitution. We report that in S. lividans, inactivation of ClpP1ClpP2 production or protease activity is indeed a mode of resistance to ADEP although it is neither the only nor the most frequent mode of resistance. The ABC transporter SclAB (orthologous to the Streptomyces coelicolor multidrug resistance pump SCO4959-SCO4960) is also able to confer ADEP resistance, and analysis of strains with sclAB deletions indicates that there are also other mechanisms of ADEP resistance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21636652     DOI: 10.1099/mic.0.048454-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  11 in total

1.  Crystal structure of Mycobacterium tuberculosis ClpP1P2 suggests a model for peptidase activation by AAA+ partner binding and substrate delivery.

Authors:  Karl R Schmitz; Daniel W Carney; Jason K Sello; Robert T Sauer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

Review 2.  Bacterial proteases, untapped antimicrobial drug targets.

Authors:  Elizabeth Culp; Gerard D Wright
Journal:  J Antibiot (Tokyo)       Date:  2016-11-30       Impact factor: 2.649

Review 3.  Bacterial proteolytic complexes as therapeutic targets.

Authors:  Ravikiran M Raju; Alfred L Goldberg; Eric J Rubin
Journal:  Nat Rev Drug Discov       Date:  2012-10       Impact factor: 84.694

4.  Enzymatic resistance to the lipopeptide surfactin as identified through imaging mass spectrometry of bacterial competition.

Authors:  B Christopher Hoefler; Karl V Gorzelnik; Jane Y Yang; Nathan Hendricks; Pieter C Dorrestein; Paul D Straight
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

5.  The ADEP Biosynthetic Gene Cluster in Streptomyces hawaiiensis NRRL 15010 Reveals an Accessory clpP Gene as a Novel Antibiotic Resistance Factor.

Authors:  Dhana Thomy; Elizabeth Culp; Martina Adamek; Eric Y Cheng; Nadine Ziemert; Gerard D Wright; Peter Sass; Heike Brötz-Oesterhelt
Journal:  Appl Environ Microbiol       Date:  2019-10-01       Impact factor: 4.792

6.  ClpP inhibitors are produced by a widespread family of bacterial gene clusters.

Authors:  Elizabeth J Culp; David Sychantha; Christian Hobson; Andrew C Pawlowski; Gerd Prehna; Gerard D Wright
Journal:  Nat Microbiol       Date:  2022-03-04       Impact factor: 30.964

7.  Antibacterial activity of and resistance to small molecule inhibitors of the ClpP peptidase.

Authors:  Corey L Compton; Karl R Schmitz; Robert T Sauer; Jason K Sello
Journal:  ACS Chem Biol       Date:  2013-10-04       Impact factor: 5.100

Review 8.  Reprogramming of the Caseinolytic Protease by ADEP Antibiotics: Molecular Mechanism, Cellular Consequences, Therapeutic Potential.

Authors:  Heike Brötz-Oesterhelt; Andreas Vorbach
Journal:  Front Mol Biosci       Date:  2021-05-13

9.  Comparative genomics of transport proteins in developmental bacteria: Myxococcus xanthus and Streptomyces coelicolor.

Authors:  Ilya Getsin; Gina H Nalbandian; Daniel C Yee; Ake Vastermark; Philipp C G Paparoditis; Vamsee S Reddy; Milton H Saier
Journal:  BMC Microbiol       Date:  2013-12-05       Impact factor: 3.605

10.  Restriction of the conformational dynamics of the cyclic acyldepsipeptide antibiotics improves their antibacterial activity.

Authors:  Daniel W Carney; Karl R Schmitz; Jonathan V Truong; Robert T Sauer; Jason K Sello
Journal:  J Am Chem Soc       Date:  2014-01-24       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.